Eisai's Corporate Concept is to give first thought to patients and the people in the daily living domain, and to increase the benefits that healthcare provides to them as well as meet their diversified healthcare needs worldwide. Eisai calls this the “human health care (hhc)” concept. In order to achieve this mission, we are implementing activities globally to empathize with thoughts and feelings that might not necessarily always be expressed in words and see the situation from the patient's perspective through "socialization" which means spending time with patients. In the drug development process as well, we value awareness of new perspectives through such socialization with patients.
Patients have concerns about side effects, expectations for future treatment, and difficulties with treatment conditions such as hospital visits. By confronting patients’ earnest feelings, we gain valuable insights and are working to reflect the voices of patients in our drug development plans and clinical trial protocols. In addition, we strive to create easy-to-understand informed consent documents to reduce anxiety about participating in clinical trials and to help patients understand the significance of each test in clinical trials. Furthermore, in order to reduce the burden of the hospital visits, we implement decentralized clinical trials using home-visit nursing and telemedicine, etc., so that patients can participate in clinical trials from home if they need. The opinions and insights we gain from discussions with patients are essential in tackling the challenge of designing clinical trials that are easier for patients to participate in.
Based on our hhc concept, we will continue to be close to patients, cultivate clinical development that responds to their feelings, and make further contributions to patients.